These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38267570)

  • 1. Author Correction: Increased risk of chronic kidney disease in uric acid stone formers with high neutrophil-to-lymphocyte ratio.
    Tung HT; Liu CM; Huang HS; Lu ZH; Liu CJ
    Sci Rep; 2024 Jan; 14(1):2096. PubMed ID: 38267570
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased risk of chronic kidney disease in uric acid stone formers with high neutrophil-to-lymphocyte ratio.
    Tung HT; Liu CM; Huang HS; Lu ZH; Liu CJ
    Sci Rep; 2023 Oct; 13(1):17686. PubMed ID: 37848540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal Changes in Kidney Stone Composition and in Risk Factors Predisposing to Stone Formation.
    Xu LHR; Adams-Huet B; Poindexter JR; Maalouf NM; Moe OW; Sakhaee K
    J Urol; 2017 Jun; 197(6):1465-1471. PubMed ID: 28111301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Urinary Inhibitor or Promoter Activity in Uric Acid Nephrolithiasis.
    Doizi S; Rodgers K; Poindexter J; Sakhaee K; Maalouf NM
    J Urol; 2016 Jun; 195(6):1799-804. PubMed ID: 26723865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers.
    Srinivasan S; Kalaiselvi P; Sakthivel R; Pragasam V; Muthu V; Varalakshmi P
    Clin Chim Acta; 2005 Mar; 353(1-2):45-51. PubMed ID: 15698589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes.
    Bobulescu IA; Maalouf NM; Capolongo G; Adams-Huet B; Rosenthal TR; Moe OW; Sakhaee K
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1498-503. PubMed ID: 24026180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney stone formation is positively associated with conventional risk factors for coronary heart disease in Japanese men.
    Ando R; Nagaya T; Suzuki S; Takahashi H; Kawai M; Okada A; Yasui T; Kubota Y; Umemoto Y; Tozawa K; Kohri K
    J Urol; 2013 Apr; 189(4):1340-6. PubMed ID: 23159273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences of Uric Acid Transporters Carrying Extracellular Vesicles in the Urine from Uric Acid and Calcium Stone Formers and Non-Stone Formers.
    Lin Z; Jayachandran M; Haskic Z; Kumar S; Lieske JC
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial Differences in Risk Factors for Kidney Stone Formation.
    Zisman AL; Coe FL; Cohen AJ; Riedinger CB; Worcester EM
    Clin J Am Soc Nephrol; 2020 Aug; 15(8):1166-1173. PubMed ID: 32561654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension in kidney stone patients.
    Cupisti A; Morelli E; Meola M; Cozza V; Parrucci M; Barsotti G
    Nephron; 1996; 73(4):569-72. PubMed ID: 8856253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diurnal variation in urine acidification differs between normal individuals and uric acid stone formers.
    Cameron M; Maalouf NM; Poindexter J; Adams-Huet B; Sakhaee K; Moe OW
    Kidney Int; 2012 Jun; 81(11):1123-30. PubMed ID: 22297671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
    Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR
    Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers.
    Asokan D; Kalaiselvi P; Muhammed Farooq S; Varalakshmi P
    Urol Res; 2004 Oct; 32(5):357-61. PubMed ID: 15365653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uric acid-binding proteins in calcium oxalate stone formers and their effect on calcium oxalate crystallization.
    Kalaiselvi P; Udayapriya KL; Selvam R
    BJU Int; 1999 Jun; 83(9):919-23. PubMed ID: 10368229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Hypertension among First-Time Symptomatic Kidney Stone Formers.
    Kittanamongkolchai W; Mara KC; Mehta RA; Vaughan LE; Denic A; Knoedler JJ; Enders FT; Lieske JC; Rule AD
    Clin J Am Soc Nephrol; 2017 Mar; 12(3):476-482. PubMed ID: 28148559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers.
    Stern JM; Moazami S; Qiu Y; Kurland I; Chen Z; Agalliu I; Burk R; Davies KP
    Urolithiasis; 2016 Oct; 44(5):399-407. PubMed ID: 27115405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on circadian periodicity of serum and urinary urate in healthy Indians and renal stone formers.
    Singh RK; Bansal A
    Prog Clin Biol Res; 1987; 227B():305-13. PubMed ID: 3628342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.